V. Beliakouski

发表

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

M. Espié, M. Campone, J. Cortés, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Biopsy of pancreatic tumors prior to resection: for and against

I. V. Mikhailov, V. Beliakouski, A. Dyatlov, 2021, Health and Ecology Issues.

LBA27 Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results from the NORSE study

T. Powles, A. Santiago-Walker, T. Kang, 2021, Annals of Oncology.

Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.

T. Ciuleanu, S. Orlov, H. Breitz, 2010 .